{"title":"阿瑞吡坦与标准治疗(5-HT3 +皮质类固醇)相比预防高致吐性化疗引起的恶心和呕吐的成本-后果分析","authors":"R. Ravasio, G. Rosti","doi":"10.5301/GRHTA.5000195","DOIUrl":null,"url":null,"abstract":"IntroductionPrevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving cytotoxic treatment. The objective of this study was to assess, from the I...","PeriodicalId":228031,"journal":{"name":"Global and Regional Health Technology Assessment","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Cost-consequence analysis of aprepitant compared to standard therapy (5-HT3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomit\",\"authors\":\"R. Ravasio, G. Rosti\",\"doi\":\"10.5301/GRHTA.5000195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IntroductionPrevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving cytotoxic treatment. The objective of this study was to assess, from the I...\",\"PeriodicalId\":228031,\"journal\":{\"name\":\"Global and Regional Health Technology Assessment\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global and Regional Health Technology Assessment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5301/GRHTA.5000195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global and Regional Health Technology Assessment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5301/GRHTA.5000195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cost-consequence analysis of aprepitant compared to standard therapy (5-HT3 + corticosteroids) for the prevention of highly emetogenic chemotherapy-induced nausea and vomit
IntroductionPrevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving cytotoxic treatment. The objective of this study was to assess, from the I...
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
